口服咖啡因在白内障患者晶状体囊膜/上皮的药代动力学初步随机对照研究
本研究纳入双侧白内障患者,术前禁咖啡因1周,第二眼手术日分别给予0、60、120、180 mg咖啡因(咖啡),用GC-MS/MS测晶状体囊膜/上皮咖啡因浓度。咖啡因组浓度较第一眼显著升高(P<0.05),呈剂量依赖;0 mg组差值为-0.52 ± 1.16,180 mg组为3.68 ± 1.86。
要点
- 口服咖啡后晶状体囊膜/上皮咖啡因浓度显著升高(P<0.05)。
- 60、120、180 mg组浓度升高呈剂量依赖。
- 0 mg组双眼差值为-0.52 ± 1.16(n=7)。
核心结论
- 口服咖啡显著增加晶状体囊膜和晶状体上皮细胞中的咖啡因浓度,且呈剂量依赖。
- 该信息对进一步研究预防白内障具有重要意义。
研究设计与样本
- 初步随机对照研究,纳入双侧白内障患者,每眼术前禁咖啡因1周。
- 第二眼手术日给予无饮料(0 mg组)或含60、120、180 mg咖啡因的咖啡。
- 撕囊后将含晶状体上皮细胞的晶状体囊膜转入试管,用气相色谱-串联质谱(GC-MS/MS)测咖啡因浓度。
主要发现
- 60、120、180 mg组咖啡因显著升高晶状体囊膜/上皮咖啡因水平(P<0.05)。
- 双眼间咖啡因浓度差值:0 mg组-0.52 ± 1.16(n=7),60 mg组1.88 ± 2.02(n=8),120 mg组2.09 ± 0.67(n=9),180 mg组3.68 ± 1.86(n=9)。
- 线性回归模型估计咖啡因增加常数为95%CI 0.02 ± 0.0046(自由度25;r=0.85)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the pharmacokinetics of perorally administered caffeine, a widely consumed and potent dietary antioxidant, in the anterior lens capsule and lens epithelial cells, a crucial cell monolayer for cataract development. METHODS: Bilateral cataract patients were scheduled for cataract surgery with a caffeine abstinence of 1 week before surgery of each eye. At the day of surgery of the second eye patients were administered no drink (0-mg group) or coffee with 60-, 120-, or 180-mg caffeine. After capsulorhexis the lens capsule including lens epithelial cells was transferred to a test tube for analysis of caffeine concentration by gas chromatography-mass spectrometry (GC-MS/MS). RESULTS: Coffee consumption significantly (P < 0.05) increased caffeine levels of the lens capsule/epithelium in the 60-, 120-, and 180-mg group. Caffeine concentrations (caffeine ng/lens capsule/epithelium) measured as difference between 1st and 2nd eye were -0.52 ± 1.16 (0-mg group, n = 7), 1.88 ± 2.02 (60-mg group, n = 8), 2.09 ± 0.67 (120-mg group, n = 9), and 3.68 ± 1.86 (180-mg group, n = 9). The increase constant of caffeine in a linear regression model was estimated as a 95% CI 0.02 ± 0.0046 (degrees of freedom; 25; r = 0.85). CONCLUSIONS: Peroral intake of coffee significantly increased caffeine concentrations in the lens capsule and lens epithelial cells in a dose-dependent manner. This information is important for further investigations on preventing cataract.
引用
- Kronschläger M, Stimpfl T, Ruiß M, et al. Pharmacokinetics of Caffeine in the Lens Capsule/Epithelium After Peroral Intake: A Pilot Randomized Controlled Study. Invest Ophthalmol Vis Sci. 2018. PMID: 29677345. doi:10.1167/iovs.18-23963
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。